
The State Food and Drug Administration and the State Administration for Industry and Commerce issued the newly-revised Provisions for Drug Advertisement Examination on March 15, 2007. After the implementation of the Provisions as of May 1, 2007, China's drug advertisement management will be further intensified.
The newly-revised Provisions for Drug Advertisement Examination comprise 31 articles, and made specific regulations on the procedures and time limit of the approval and filing of drug advertisement, applicant's obligations, supervision of drug advertisement and relevant legal liabilities.
(From: SFDA)